Becton, Dickinson and Company

FAIRBDX · NYSE · Healthcare
BDX·NYSE·Healthcare
FAIR VALUE
Becton, Dickinson and Company
0.1%fair value
MARKET PRICE
$147.76
FAIR PRICE
$147.58
MARGIN
$0.18
UNDERVALUEDFAIROVERVALUED
P/E RATIO
24.4x
DIV. YIELD
2.35%
ROE
6.4%
MARKET CAP
$54B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

0.1%fair value

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$147.76

FAIR PRICE

$147.58

MARGIN

$0.18

UNDERVALUEDFAIROVERVALUED

P/E Ratio

24.4x

What is P/E? →

Div. Yield

2.35%

ROE

6.4%

Average

Market Cap

$54B

Large-cap

NOW AVAILABLE

Get notified when BDX's fair price changes

Push notifications when BDX's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

4.4/ 10

Strong profitability, but below-average fundamental quality.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$118.06CONSERVATIVE ENTRY
$147.58FAIR PRICE
$147.76MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$118.06

Fair price × 0.80

DISTANCE

20.1%

Price to entry level

At the current price of $147.76, BDX trades 20.1% above the conservative entry level of $118.06. This entry level represents a 20% margin of safety below the calculated fair price of $147.58 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate BDX's fair price

Becton, Dickinson and Company's fair price of $147.58 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $147.76, BDX trades 0.1% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BDX's risk profile.

RELATIVE · 30%

Comparing BDX's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for BDX, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate BDX's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for BDX.

Explore on Bulios

FAQ

What is the fair price of BDX?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Becton, Dickinson and Company is $147.58. At the current market price of $147.76, BDX trades 0.1% above its calculated fair value.

Is BDX overvalued or undervalued?+

Becton, Dickinson and Company is currently fair based on our valuation model. The stock trades at $147.76, which is 0.1% above the fair price of $147.58. The P/E ratio of 24.4x is a key metric in the valuation.

What is the margin of safety for BDX?+

With a 20% margin of safety applied to the fair price of $147.58, the conservative entry level for BDX is $118.06. At the current market price of $147.76, the stock trades 20.1% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is BDX's fair price updated?+

We update fair price calculations for BDX daily after market close. The current fair price of $147.58 incorporates the latest market data and sector multiples.

What factors affect BDX's fair price calculation?+

BDX's fair price of $147.58 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 24.4x, ROE of 6.4%, and dividend yield of 2.35%.

Is BDX a good buy right now?+

At $147.76, BDX trades 0.1% above our fair value estimate of $147.58. The stock is currently fair. ROE stands at 6.4% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does BDX pay dividends?+

BDX has a dividend yield of 2.35%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.